ATE81979T1 - Pharmazeutische zusammensetzung und verfahren zur virushemmung. - Google Patents

Pharmazeutische zusammensetzung und verfahren zur virushemmung.

Info

Publication number
ATE81979T1
ATE81979T1 AT90908811T AT90908811T ATE81979T1 AT E81979 T1 ATE81979 T1 AT E81979T1 AT 90908811 T AT90908811 T AT 90908811T AT 90908811 T AT90908811 T AT 90908811T AT E81979 T1 ATE81979 T1 AT E81979T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
methods
virus inhibition
butyl
virus
Prior art date
Application number
AT90908811T
Other languages
English (en)
Inventor
Martin Stanley Hirsch
Victoria Anne Johnson
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE81979T1 publication Critical patent/ATE81979T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90908811T 1989-06-02 1990-05-09 Pharmazeutische zusammensetzung und verfahren zur virushemmung. ATE81979T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/360,439 US5011829A (en) 1989-06-02 1989-06-02 Pharmaceutical composition and method of inhibiting virus
PCT/US1990/002587 WO1990014830A1 (en) 1989-06-02 1990-05-09 Pharmaceutical composition and method of inhibiting virus

Publications (1)

Publication Number Publication Date
ATE81979T1 true ATE81979T1 (de) 1992-11-15

Family

ID=23417957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908811T ATE81979T1 (de) 1989-06-02 1990-05-09 Pharmazeutische zusammensetzung und verfahren zur virushemmung.

Country Status (10)

Country Link
US (1) US5011829A (de)
EP (2) EP0437554B1 (de)
JP (1) JPH04500220A (de)
AT (1) ATE81979T1 (de)
CA (1) CA2030803A1 (de)
DE (1) DE69000434T2 (de)
DK (1) DK0437554T3 (de)
IE (1) IE64352B1 (de)
PT (1) PT94247B (de)
WO (1) WO1990014830A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
EP0547140A4 (en) * 1990-09-06 1993-10-13 The Australian National University Immunosuppressant composition
AU654152B2 (en) * 1990-09-06 1994-10-27 Australian National University, The Immunosuppressant composition
CZ285232B6 (cs) * 1991-05-16 1999-06-16 Glaxo Group Limited Protivirové směsi
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
DE69317428T2 (de) * 1992-08-19 1998-07-02 Schering Corp., Kenilworth, N.J. Methode zur inhibition von hiv-replikation mittels il-4
US6291657B1 (en) * 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
US5798366A (en) * 1993-05-13 1998-08-25 Monsanto Company Method for treatment of CNS-involved lysosomal storage diseases
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
CA2309321A1 (en) 1997-11-10 1999-05-20 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
AU762125B2 (en) 1998-02-12 2003-06-19 G.D. Searle & Co. Use of (N)-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
AU3595500A (en) 1999-02-12 2000-08-29 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
US6569616B1 (en) * 1999-07-29 2003-05-27 Wisconsin Alumni Research Foundation Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
EP1261339A1 (de) * 2000-02-14 2002-12-04 Pharmacia Corporation Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitolverbindungen zur behandlung von hepatitisvirusinfektionen
WO2006037069A1 (en) * 2004-09-28 2006-04-06 Allergan, Inc. Compositions comprising nb-dnj, ne-dnj or d-glucaro-delta-lactam and their uses for the treatment of pain and other neurological conditions
KR20080025373A (ko) * 2005-05-17 2008-03-20 아미쿠스 세라퓨틱스, 인코포레이티드 1-데옥시노지리마이신 및 유도체를 이용한 폼페병의 치료방법
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
KR20230066482A (ko) 2012-03-07 2023-05-15 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병의 치료를 위한 고농도 알파-글루코시다제 조성물
AU2015325028B2 (en) 2014-09-30 2022-02-24 Amicus Therapeutics, Inc. Highly potent acid alpha-glucosidase with enhanced carbohydrates
MY198085A (en) 2015-12-30 2023-07-31 Amicus Therapeutics Inc Augmented acid alpha-glucosidase for the treatment of pompe disease
KR102444612B1 (ko) 2016-03-30 2022-09-21 아미쿠스 세라퓨틱스, 인코포레이티드 재조합 산 알파-글루코시다제를 포함하는 제형
AU2017239640B2 (en) 2016-03-30 2022-07-28 Amicus Therapeutics, Inc. Method for selection of high M6P recombinant proteins
CN109456254B (zh) * 2018-12-06 2020-06-30 江西农业大学 1-脱氧野尻霉素-羟基查尔酮杂合体衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4857511A (en) * 1985-09-17 1989-08-15 Burroughs Wellcome Co. Treatment of human viral infections
JPS63175354A (ja) * 1987-01-16 1988-07-19 Shin Kobe Electric Mach Co Ltd 電池用渦巻電極体の製造装置
EP0282618A1 (de) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin als Anti-HIV-Therapeutikum
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
IE64352B1 (en) 1995-07-26
DE69000434T2 (de) 1993-05-27
EP0437554B1 (de) 1992-11-04
WO1990014830A1 (en) 1990-12-13
PT94247B (pt) 1997-05-28
DK0437554T3 (da) 1992-12-07
IE901973L (en) 1990-12-02
US5011829A (en) 1991-04-30
DE69000434D1 (de) 1992-12-10
CA2030803A1 (en) 1990-12-03
EP0401194A1 (de) 1990-12-05
EP0437554A1 (de) 1991-07-24
JPH04500220A (ja) 1992-01-16
PT94247A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
ATE81979T1 (de) Pharmazeutische zusammensetzung und verfahren zur virushemmung.
ATE232095T1 (de) Verbindungen und verfahren zur inhibierung von hiv- und verwandten viren
EP0246809A3 (en) Sustained-release pharmaceutical compositions
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE148632T1 (de) Synergistische therapeutische zusammensetzungen und verfahren
DK0430474T3 (da) Præparater med vedvarende frigivelse til behandling af periodontal sygdom
FI956210A (fi) Kerran päivässä suun kautta otettava metoprololiannosmuoto
PT87703A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um derivado de 1,4-di-hidropiridina e um intensificador do fluxo transdermico
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69118526D1 (de) Mittel zur transdermalen penetration von arzneimitteln
ATE141514T1 (de) Verfahren zur verhütung, stabilisierung oder verursachung des zurückgangs von atherosklerose durch anwendung einer mischung von einem cholesterol-vermindernden arzneimittel mit einem ace-inhibitor
DE68927160D1 (de) Verwendung von N-Butyl-Deoxynojirimycin zur Behandlung von Herpes
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DK249688D0 (da) Laegemiddelkombination til forebyggelse og behandling af malaria
IL89793A0 (en) Pharmaceutical composition for treating patients having a retrovirus infection and method for the preparation thereof
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
NZ237340A (en) N-benzoyl-4-indanyl-(and tetrahydronaphthalenyl-)aminomethyl piperidine derivatives; preparatory processes and pharmaceutical compositions
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
IL94558A0 (en) Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO20021625L (no) Synergistiske kombinasjoner av en NK1 reseptor antagonist og en GABA strukturell analog
NZ234124A (en) Piperidine derivatives and pharmaceutical compositions
DE59106712D1 (de) Vorrichtung zum Abziehen oder Entfernen von Zahnkronen und -brücken.
PT89266A (pt) Metodo para a inibicao de virus da imunodeficiencia humana utilizando um derivado n-n-butilo de desoxinojirimicina
AU6962894A (en) Compositions and methods for inhibiting replication of human immunodeficiency virus-1